Kiniksa Pharmaceuticals International, plc (KNSA) vs Dr. Reddy's Laboratories Ltd (RDY)
- Kiniksa Pharmaceuticals International, plc KNSA 78.59 −1.69%
- Dr. Reddy's Laboratories Ltd RDY 13.05 +1.16%
Kiniksa Pharmaceuticals International, plc and Dr. Reddy's Laboratories Ltd are both Drug Manufacturers Specialty & Generic companies. Dr. Reddy's Laboratories Ltd is the larger, with a market value of $10.7B against $6.2B — 1.7× the size. Dr. Reddy's Laboratories Ltd trades at the lower P/E: 32.9× against 73.4×. Kiniksa Pharmaceuticals International, plc grew revenue faster over the last twelve months: 58.9% against −11.6%. Dr. Reddy's Laboratories Ltd has the higher net margin (9.81% vs 9.59%) and the lower return on invested capital (5.89% vs 48.9%). Across the 21 metrics below, Kiniksa Pharmaceuticals International, plc leads on 13 and Dr. Reddy's Laboratories Ltd on 8.
Valuation
Profitability
| Metric | KNSA | RDY | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 89.82% | 50.00% | 53.94% |
| Operating margin | 11.92% | 10.91% | 0.00% |
| Net margin | 9.59% | 9.81% | 0.00% |
| Free cash flow margin | 21.74% | 4.05% | 0.00% |
| Return on equity | 14.04% | 8.21% | (0.40%) |
| Return on assets | 10.36% | 5.55% | (3.32%) |
| Return on invested capital | 48.87% | 5.89% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack